Driving Growth & Revenue Optimization for Healthcare Practices

Welcome to Magnolia Consulting Group

Trusted Healthcare Solutions. Proven Revenue Results.

At Magnolia Consulting, we specialize in driving financial performance for healthcare providers across the country. From revenue cycle management and forensic audits to wound care strategy and compliance support, we help medical practices, hospitals, and health systems recover lost revenue and streamline operations without disrupting existing workflows.

With a team of over 2,000 seasoned industry professionals, we bring a strategic approach to helping you grow your business. Whether you're facing millions in A/R or looking to scale your practice efficiently, our solutions are built to deliver measurable results—fast.

No long-term contracts. No system overhauls. Just smart, effective consulting tailored to your needs.

Magnolia Consulting —where healthcare meets precision finance.

Case Studies

Learn more
  • Smarter Billing. Stronger Revenue.

    Magnolia Revenue Cycle Solutions delivers a comprehensive, white-glove billing and coding service designed to help healthcare providers increase collections, reduce denials, and gain complete clarity over their financial performance.

    Our team manages the entire revenue cycle—from eligibility and coding to claim submission, A/R follow-up, and denial recovery—ensuring practices get paid fully, accurately, and on time. With daily billing, specialty-trained coders, and transparent reporting, Magnolia functions as a seamless extension of your office.

    A Better Revenue Experience for Providers

    Fast, Accurate Billing

    Daily claim submission, precise coding, and proactive payer follow-up help reduce days in A/R and accelerate payments.

    Denial Prevention & Recovery

    We identify root causes, correct issues in real time, and aggressively recover denied or underpaid claims.

    Eligibility, Authorizations & Enrollment

    Front-end accuracy prevents costly mistakes—ensuring coverage is verified, authorizations secured, and providers properly enrolled.

    Transparent Reporting

    Real-time analytics and monthly executive dashboards provide clear visibility into cash flow, denials, and performance trends.

    Why Practices Choose Magnolia

    Higher clean claim rates

    Faster reimbursement cycles

    A/R cleanup and denial reduction

    Dedicated account management

    Compliance-focused processes

    Scalable support for growing organizations

    Magnolia delivers the expertise, transparency, and performance providers need to improve revenue, reduce administrative stress, and operate with confidence.

  • Smarter Care. Lower Costs. Real Transparency.

    HealthLock+ is Magnolia’s advanced healthcare navigation and cost-protection platform—designed to help employees make smarter medical decisions while empowering employers to reduce claims waste, improve plan efficiency, and maintain compliance.

    Built with intelligent automation, real-time data, and human clinical oversight, HealthLock+ transforms a confusing, expensive healthcare system into a clear, predictable, and patient-friendly experience.
    We help every member understand where to go, what it will cost, and how to get the highest-quality care at the lowest possible price.

    A Better Healthcare Experience for Employees & Employers

    Helping Employees Make Smart Healthcare Choices

    HealthLock+ guides members through every step of their care journey—from choosing the right provider to understanding treatment costs before an appointment is ever scheduled. With real-time plan data and clear benefit explanations, employees gain confidence and avoid surprise bills.

    Reducing Waste & Improving Savings for Employers

    By optimizing plan utilization and steering members toward high-value providers, HealthLock+ lowers unnecessary spending while increasing overall employee satisfaction. Employers benefit from improved claims efficiency, stronger compliance, and meaningful cost control across their health plan.

    What Makes HealthLock+ Different?

    AI-Driven Care Navigation

    Members receive personalized guidance to high-quality, cost-effective providers matched to their plan and medical needs.

    Real-Time Price Transparency

    HealthLock+ instantly compares costs for tests, procedures, imaging, and specialist visits—empowering members to choose the best value.

    Accurate Out-of-Pocket Estimates

    By analyzing deductibles, co-pays, and benefit limits, HealthLock+ provides a true picture of expected costs before care is delivered.

    Encounter Estimate™ Technology

    A unique bundled prediction tool that reveals downstream, associated, and follow-up costs to eliminate surprise medical bills.

    MyMedicalRewards™ Program

    Members earn cash rewards for selecting high-value, high-quality providers—driving smarter utilization and lowering plan expenses.

    Compliance & Cost Protection

    HealthLock+ helps employers remain aligned with federal transparency requirements, including the No Surprises Act, while preventing billing errors and overcharges.

    The Result: A Healthier, More Transparent Healthcare Ecosystem

    HealthLock+ delivers clarity, confidence, and peace of mind for employees—while giving employers unprecedented control over costs and plan performance.
    It is proactive, data-driven, and purpose-built to simplify the healthcare experience for everyone it serves.

  • Advanced Biologics for Faster, More Predictable Healing.

    Magnolia Wound Care Solutions delivers a clinically proven portfolio of amnion allografts designed to accelerate healing for chronic and complex wounds. Our products are processed using proprietary technology that preserves the tissue’s natural growth factors, structural integrity, and biologic activity—giving providers a powerful, minimally invasive option for treating high-risk patients.

    With upcoming CMS changes. We are happy to say that we are 1 of less than 10 Manufacturers approved for Diabetic Foot Ulcers (DFUs) and 1–5 that will be approved for Venous Leg Ulcers (VLUs) in 2026, our allografts will be fully aligned with national coverage criteria, enabling predictable reimbursement and broader access for patients who need it most.

    *In 2027 We will be the only 351A Biologic Licensed CTP on the market *

    Magnolia gives physicians the ability to deliver medical-grade healing solutions backed by science, consistency, and strong payer alignment.

    A Better Healing Experience for Providers & Patients

    Patented Dehydrated Amnion Allografts

    Our allografts maintain their native extracellular matrix, growth factors, and biologic signaling properties—supporting faster tissue regeneration and improved wound closure rates.

    Designed for Chronic & Complex Wounds

    Indicated for DFUs, VLUs, pressure ulcers, trauma wounds, surgical dehiscence, burns, and other difficult-to-heal presentations.

    Predictable Reimbursement Pathways

    With CMS-recognized application allowances, Magnolia’s biologics offer consistent coverage, simplified treatment planning, and increased financial predictability for both physicians and facilities.

    Easy to Use. Easy to Store. Highly Versatile.

    Our dehydrated format provides excellent shelf stability, rapid rehydration, and flexible application options for diverse wound types.

    Why Providers Choose Magnolia Wound Care

    Clinical Strength – Naturally rich in regenerative components that support faster healing.

    Physician-Centered Support – Dedicated onboarding, education, and reimbursement guidance.

    Streamlined Distribution – Reliable ordering, fast delivery, and consistent inventory access.

    Magnolia Wound Care Solutions empowers providers to deliver better outcomes with biologics engineered for performance, compliance, and healing success.

  • The Only Legally Injectable 351(a) MSC Exosome Product on the Market.

    Over 700 Growth Factors with over 20 Billion Exosomes per ML.

    Magnolia Regenerative Medicine delivers the first and only MSC-derived exosome product in the marketplace manufactured under the FDA’s 351(a) biologic framework, providing a truly compliant pathway for injectable clinical use.

    While most exosome or extracellular vesicle products fall under enforcement discretion or lack a clear regulatory category, Magnolia’s 351(a)-classified exosome platform is produced using drug-level manufacturing standards, including controlled donor sourcing, cGMP processing, potency validation, and sterility assurance.

    The result: a legally injectable, fully compliant, physician-ready exosome product unlike anything else available in the U.S. today.

    A Higher Standard of Regenerative Compliance & Safety

    351(a) Biologic Classification

    Our exosome product aligns with the FDA’s strict 351(a) requirements, which govern biologics that require controlled manufacturing, characterization, and safety validation—far exceeding the standards of typical tissue products.

    Legally Injectable Formulation

    Because the product meets 351(a) biologic criteria, it can be used as an injectable, setting it apart from other exosome products that cannot legally be administered in this route under current regulations.

    True MSC-Derived Exosomes

    Not lysates, not “secretomes,” not unverified vesicle suspensions—Magnolia delivers highly purified, well-characterized MSC-derived extracellular vesicles.

    Drug-Level Manufacturing Standards

    Produced under full cGMP, donor-screened, potency-tested, and validated for particle concentration, identity, sterility, and bioactivity.

    Why Magnolia’s 351(a) Exosomes Are Different

    Only legally injectable exosome product meeting 351(a) biologic criteria

    Fully compliant with FDA biologic manufacturing requirements

    High-purity MSC extracellular vesicles with defined characterization

    Reproducible potency, consistency, and safety controls

    Suitable for orthopedic, regenerative, aesthetic, and wound care applications

    Magnolia Regenerative Medicine sets the new standard for exosome-based therapies—bringing providers a fully compliant, high-potency, next-generation biologic that elevates clinical practice while eliminating regulatory uncertainty.